Clinical Trial Search

Primary: Contraceptive Efficacy of Relugolix Combination Therapy as Assessed by the At-Risk Pearl Index (PI) — 1.27 Pregnancies per 100 woman-years

Primary: Number of Participants With at Least One Treatment-Related TEAE — 101; 75; 17 Participants

Primary: Duration of Agitation (in Hours), Defined by a RASS ≥ +1 — 1; 2 hours

Primary: Change From Baseline in Pre-dose Morning First Expiratory Volume in 1 Second (FEV1) in Patients With Chronic Obstructive Pulmonary Disease (COPD) — -0.020; -0.019 liters…

Primary: Double Blind (DB) Treatment Phase: Change From Baseline to Day 43 in Montgomery- Asberg Depression Rating Scale (MADRS) Total Score- Estimand 1 — -10.5; -12.9 Units on a…

Primary: Change in Glycated Haemoglobin (HbA1c) [Noninferiority] — -1.37; -0.65 Percentage point of HbA1c

Primary: Number of Participants With Solicited Injection-site Adverse Events (AEs) in RSV Season 1 — 31; 32; 39; 54 Participants

Primary: Time to First Severe Asthma Exacerbation — NA; NA weeks

Primary: Percentage Change in Body Weight — -15.8; -2.2 Percentage (%) change in body weight — p=<0.0001

Primary: Change in Percentage Ventilated Defect Percent (VDP) — -0.14 % change in VDP

Primary: Percentage of Participants With at Least 1 Local Reaction of Any Grade for up to 7 Days Following Study Vaccination 1 — 80.8; 34.8; 80.6; 14.6 Percentage of participants

Primary: The Percent Change in Daytime Cough Frequency (Coughs Per Hour) — -40.8; -4.3 % change

Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 6 — -14.3; -12.2 Score on a Scale — p=0.1115

Primary: Change in Neuropathic Pain Score at 2 Months (Numeric Rating Scale 0-10) — 4.1; 4.6 units on a scale

Primary: Society of Thoracic Surgery (STS) Quality Benchmark of Early Extubation Criteria — 31; 31 Participants